Meeting
2018 Gastrointestinal Cancers Symposium
Serial monitoring of circulating tumor DNA in patients with metastatic colorectal cancer to predict the therapeutic response.
Authors
Jianfeng Zhou
Peking Union Medical College Hospital/ Chinese Academy of Medical Sciences, Beijing, China
Jianfeng Zhou , Ning Jia , Zhao Sun , Xin Gao , Yuejuan Cheng , Wei Chen , Chunying Shen , Chunmei Bai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 713)
DOI
10.1200/JCO.2018.36.4_suppl.713
Abstract #
713
Poster Bd #
H2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
GaEsSeer: Early detection of gastric and esophageal cancer by integrating methylation and fragmentomics signatures in cfDNA.
First Author: Yunshi Zhong
Poster
2018 ASCO Annual Meeting
Circulating tumor DNA (ctDNA) as an early marker to monitor clinical benefit of regorafenib and TAS-102 in patients with metastatic colorectal cancer (mCRC).
First Author: Allan Andresson Lima Pereira
Poster
2018 Gastrointestinal Cancers Symposium
BEACON CRC study safety lead-in (SLI) in patients with BRAFV600E metastatic colorectal cancer (mCRC): Efficacy and tumor markers.
First Author: Eric Van Cutsem
Poster
2017 Gastrointestinal Cancers Symposium
Prospective, multi-center study of 5-fluorouracil (5-FU) therapeutic drug management (TDM) in metastatic colorectal cancer (mCRC) patients treated in routine clinical practice.
First Author: Salvatore J. Salamone